What Is Optic Nerve Atrophy?
Optic nerve atrophy (ONA) is a condition in which the optic nerve — which transmits visual information from the eye to the brain — is damaged, resulting in the death of nerve fibres and a reduction in the nerve's ability to carry visual signals. Optic nerve atrophy is not a disease in itself but rather the result of a process or condition that has damaged the optic nerve. Common causes include: glaucoma (the most common cause), ischaemic optic neuropathy (reduced blood flow to the optic nerve), optic neuritis (inflammation of the optic nerve — often associated with multiple sclerosis), trauma, tumours, hereditary conditions (such as Leber's Hereditary Optic Neuropathy), toxic or nutritional causes, and elevated intracranial pressure. Optic nerve atrophy can affect one or both eyes and causes varying degrees of vision loss depending on severity.
Common Symptoms
The symptoms of optic nerve atrophy reflect the loss of nerve fibre function and include: blurred vision or reduced visual acuity; reduced colour vision — particularly affecting red-green colour discrimination; visual field defects — areas of missing vision (scotomas); abnormal pupillary light reflex; difficulty focusing; reduced contrast sensitivity; and in severe cases, significant or total vision loss in the affected eye(s). The optic disc (where the optic nerve enters the eye) appears pale or white on ophthalmoscopic examination — this characteristic finding is key to diagnosis. Once optic nerve fibres are lost, they cannot currently be regenerated, making early identification and treatment of the underlying cause critical.
Research & Treatment Development
Despite the traditional view that optic nerve damage is irreversible, research is increasingly exploring therapeutic avenues. Active areas include: optic nerve protection and neuroprotection — using compounds that protect remaining nerve fibres from further damage; advanced medical innovation approaches targeting optic nerve repair and functional recovery; visual rehabilitation including prism therapy, contrast enhancement, and low vision aids; early diagnosis tools including optical coherence tomography (OCT) of the retinal nerve fibre layer, visual evoked potentials (VEPs), and visual field analysis; electrical stimulation approaches showing early promise in activating residual optic nerve function; and advanced imaging and monitoring systems enabling precise tracking of nerve fibre loss over time. The key principle is maximising preservation of existing function.
Our Approach at Med Cure Centre
Med Cure Centre provides specialist optic nerve atrophy assessment and personalised treatment protocols. Our ophthalmology team, led by Dr. Pallavee R. Goswami (Ophthalmology, 26 Years Experience), conducts thorough evaluation to identify the underlying cause of optic nerve damage and assess the degree of existing nerve fibre loss. We design individualised treatment protocols focused on protecting remaining nerve function, addressing modifiable causes, and supporting visual rehabilitation. We work with patients from across India and internationally, with online consultation and remote follow-up services available for international patients.
📄 Scientific References
- National Institutes of Health (NIH) — National Library of Medicine. PubMed database. pubmed.ncbi.nlm.nih.gov
- World Health Organization (WHO) — Neurological Disorders & Eye Health Resources. who.int
- American Academy of Ophthalmology / Neurology — Clinical guidelines and disease statistics. aao.org